Skip to main content
Log in

Chronic but not acute estradiol treatment protects against the neurodegenerative effects of N-methyl-d-aspartate receptor antagonists

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Drugs that block NMDA receptors, thereby inducing an NMDA receptor hypofunctional (NRHypo) state, can cause a disseminated pattern of irreversible neurodegeneration. Based on several lines of evidence, an N-methyl-d-aspartate receptor hypofunction (NRHypo) mechanism has been postulated to contribute to neurodegenerative changes in Alzheimer disease (AD). Because estrogen putatively exerts a neuroprotective effect in AD, we examined whether estrogen protects against NRHypo-induced neurodegeneration. We administered estradiol benzoate in three separate experiments to adult female rats: (1) 100 µg subcutaneously as a onetime dose, (2) 100 µg bid twice daily for 4.5 or 14 d, and 3) 300 µg twice daily for 4.5 d. Two hours after the last estradiol dose, MK-801 was administered (0.5 mg/kg subcutaneously) to produce a robust neurotoxic injury. Controls received MK-801, but no estradiol. Four hours after administration of MK-801, the severity of injury was evaluated histologically by quantitative methods previously described. Compared to controls, a single dose of estradiol produced no change in the severity of injury (p=0.24). Chronic treatment with estradiol was associated with a 25–35% reduction in the number of injured neurons (p<0.05 in all cases). We conclude that chronic but not acute estradiol treatment reduces the severity of NRHypo-induced neurodegeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Olney, J. W. (1978). In: Kainic acid as a tool in neurobiology. McGeer, E. G., Olney, J. W., and McGeer, P. L. (eds.). Raven: New York.

    Google Scholar 

  2. Watkins, J. C. (1978). In: Kainic acid as a tool in neurobiology. McGeer, E. G., Olney, J. W., and McGeer, P. L. (eds.). Raven: New York.

    Google Scholar 

  3. Olney, J. W. (1989). Biol. Psychiatry 26, 505–525.

    Article  PubMed  CAS  Google Scholar 

  4. Choi, D. W. (1992). J. Neurobiol. 23, 1261–1276.

    Article  PubMed  CAS  Google Scholar 

  5. Lipton, S. A. and Rosenberg, P. A. (1994). N. Engl. J. Med. 330(9), 613–622.

    Article  PubMed  CAS  Google Scholar 

  6. Olney, J. W., Labruyere, J., and Price, M. T. (1989). Science 244, 1360–1362.

    Article  PubMed  CAS  Google Scholar 

  7. Olney, J. W., Labruyere, J., Wang, G., Sesma, M. A., Wozniak, D. F., and Price, M. T. (1991). Science 254, 1515–1518.

    Article  PubMed  CAS  Google Scholar 

  8. Corso, T. D., Sesma, M. A., Tenkova, T. I., et al. (1997). Brain Res. 752, 1–14.

    Article  PubMed  CAS  Google Scholar 

  9. Farber, N. B., Kim, S. H., Dikranian, K., Jiang, X. P., and Heinkel, C. (2002). Mol. Psychiatry 7, 32–43.

    Article  PubMed  CAS  Google Scholar 

  10. Kim, S. H., Price, M. T., Olney, J. W., and Farber, N. B. (1999). Mol. Psychiatry 4, 344–352.

    Article  PubMed  CAS  Google Scholar 

  11. Olney, J. W., Wozniak, D. F., and Farber, N. B. (1997). Arch. Neurol. 54, 1234–1240.

    PubMed  CAS  Google Scholar 

  12. Gonzales, R. A., Brown, L. M., Jones, T. W., Trent, R. D., Westbrook, S. L., and Leslie, S. W. (1991). Neurobiol. Aging 12, 219–225.

    Article  PubMed  CAS  Google Scholar 

  13. Wenk, G. L., Walker, L. C., Price, D. L., and Cork, L. C. (1991). Neurobiol. Aging 12, 93–98.

    Article  PubMed  CAS  Google Scholar 

  14. Magnusson, K. R. and Cotman, C. W. (1993). Neurobiol. Aging 14, 197–206.

    Article  PubMed  CAS  Google Scholar 

  15. Saransaari, P. and Oja, S. S. (1995). Mech. Aging Dev. 5, 171–181.

    Article  Google Scholar 

  16. Ulas, J. and Cotman, C. W. (1997). Neuroscience 79, 973–982.

    Article  PubMed  CAS  Google Scholar 

  17. Wozniak, D. F., Dikranian, K., Ishimaru, M. J., et al. (1998). Neurobiol. Dis. 5, 305–322.

    Article  PubMed  CAS  Google Scholar 

  18. Olney, J. W., Wozniak, D. F., and Farber, N. B. (1998). Restorative Neurol. Neurosci. 13, 75–83.

    CAS  Google Scholar 

  19. Paganini-Hill, A. and Henderson, V. W. (1996). Arch. Intern. Med. 156, 2213–2217.

    Article  PubMed  CAS  Google Scholar 

  20. Hogervorst, E., Williams, J., Budge, M., Riedel, W., and Jolles, J. (2000). Neuroscience 101(3), 485–512.

    Article  PubMed  CAS  Google Scholar 

  21. Hurn, P. D. and Mhairi, M. I. (2000). J. Cereb. Blood Flow Metab. 20(4), 631–652.

    Article  PubMed  CAS  Google Scholar 

  22. Paech, K., Webb, P., Kuiper, J. M., et al. (1997). Science 277, 1508–1510.

    Article  PubMed  CAS  Google Scholar 

  23. Singer, C. A., Figueroa-Masot, X. A., Batchelor, R. H., and Dorsa, D. M. (1999). J. Neurosci. 19(7), 2455–2463.

    PubMed  CAS  Google Scholar 

  24. Dubal, D. B., Shughrue, P. J., Wilson, M. E., Merchenthaler, I., and Wise, P. M. (1999). J. Neurosci. 19(15), 6385–6393.

    PubMed  CAS  Google Scholar 

  25. Weaver, C. E., Park-Chung Mijeony, P., Gibbs, T. T., and Farb, D. H. (1997). Brain Res. 761, 338–341.

    Article  PubMed  CAS  Google Scholar 

  26. Moorandian, A. D. (1993). J. Steroid Biochem. Mol. Biol. 45, 509–511.

    Article  Google Scholar 

  27. Toran-Allerand, C. D. (2000). Novartis Found. Symp. 230, 56–69.

    Article  PubMed  CAS  Google Scholar 

  28. Woolley, C. S., Weiland, N. G., McEwen, B. S., and Schwartzkroin, P. A. (1997). J. Neurosci. 17(5), 1848–1859.

    PubMed  CAS  Google Scholar 

  29. Foy, M. R., Xu, J., Xie, X., Brinton, R. D., Thompson, R. F., and Berger, T. W. (1999). J. Neurophysiol. 81(2), 925–929.

    PubMed  CAS  Google Scholar 

  30. Weiland, N. G. (1992). Endocrinology 131, 662–668.

    Article  PubMed  CAS  Google Scholar 

  31. Cyr, M., Othman, G., Thibault, C., Morissette, M., Landry, M., and Di Paolo, T. (2001). Brain Res. Rev. 37, 153–161.

    Article  PubMed  CAS  Google Scholar 

  32. Wong, M. and Moss, R. L. (1992). J. Neurosci. 12, 3217–3225.

    PubMed  CAS  Google Scholar 

  33. Weiland, N. G. (1992). Endocrinology 131, 2697–2702.

    Article  PubMed  CAS  Google Scholar 

  34. Parducz, A., Perez, J., and Garcia-Segura, L. M. (1993). Neuroscience 53(2), 395–401.

    Article  PubMed  CAS  Google Scholar 

  35. Luine, V. N., Grattan, D. R., and Selmanoff, M. (1997). Brain Res. 747(1), 165–168.

    Article  PubMed  CAS  Google Scholar 

  36. Murphy, D. D., Cole, N. B., and Segal, M. (1998). Proc. Natl. Acad. Sci. USA 95, 11412–11417.

    Article  PubMed  CAS  Google Scholar 

  37. Rudick, C. N. and Woolley, C. S. (2001). J. Neurosci. 21(17), 6532–6543.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William H. Dribben.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dribben, W.H., Nemmers, B.M., Nardi, A.R. et al. Chronic but not acute estradiol treatment protects against the neurodegenerative effects of N-methyl-d-aspartate receptor antagonists. Endocr 21, 53–58 (2003). https://doi.org/10.1385/ENDO:21:1:53

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:21:1:53

Key Words

Navigation